[1] |
Weiss JS. Schnyder corneal dystrophy[J]. Curr Opin Ophthalmol, 2009, 20(4): 292-298.
|
[2] |
Weiss JS. More on Schnyder corneal dystrophy[J]. Ophthalmology, 2009, 116(11): 2260.
|
[3] |
Wibaut F, Van Went JM. A strange inherited corneal alteration[J]. Ned Tijdschr Geneeskd, 1924, 68: 2996-2997.
|
[4] |
Schnyder WF. Report about a new type of familial corneal disorder[J]. Schweiz Med Wschr, 1929, 10: 559-571.
|
[5] |
Schnyder WF. Disk-like inherited crytstalline inclusions in the corneal center[J]. KIin Monatsbl Augenheilkd, 1939, 103: 494-502.
|
[6] |
Glees M. Corneal crystalline dystrophy[J]. Klin Monbl Augenheilkd Augenarztl Fortbild, 1957, 131(6): 721-724.
|
[7] |
Bron AJ, Williams HP, Carruthers ME. Hereditary crystalline stromal dystrophy of Schnyder. Ⅰ. Clinical features of a family with hyperlipoproteinaemia[J]. Br J Ophthalmol, 1972, 56(5): 383-399.
|
[8] |
Garner A, Tripathi RC. Hereditary crystalline stromal dystrophy of Schnyder Ⅱ. Histopathology and ultrastructure[J]. Br J Ophthalmol, 1972, 56(5): 400-408.
|
[9] |
Thiel HJ, Voigt GJ, Parwaresch MR. Crystalline corneal dystrophy (Schnyder) in the presence of familial type Ⅱa hyperlipoproteinaemia[J]. Klin Monbl Augenheilkd, 1977, 171(5): 678-684.
|
[10] |
Burns RP, Connor W, Gipson I. Cholesterol turnover in hereditary crystalline corneal dystrophy of Schnyder[J]. Trans Am Ophthalmol Soc, 1978, 76: 184-196.
|
[11] |
Roth AM, Ekins MB, Waring GO, et al. Oval corneal opacities in beagles. III. Histochemical demonstration of stromal lipids without hyperlipidemia[J]. Invest Ophthalmol Vis Sci, 1981, 21(1): 95-106.
|
[12] |
Lisch W, Weidle EG, Lisch C, et al. Schnyder′s dystrophy: Progression and metabolism[J]. Ophthalmic Paediatr Genet, 1986, 7(1): 45-56.
|
[13] |
Rodrigues MM, Kruth HS, Krachmer JH, et al. Unesterified cholesterol in Schnyder′s corneal crystalline dystrophy[J]. Am J Ophthalmol, 1987, 104(2): 157-163.
|
[14] |
Rodrigues MM, Kruth HS, Krachmer JH, et al. Cholesterol localization in ultrathin frozen sections in Schnyder′s corneal crystalline dystrophy[J]. Am J Ophthalmol, 1990, 110(5): 513-517.
|
[15] |
Brownstein S, Jackson WB, Onerheim RM. Schnyder′s crystalline corneal dystrophy in association with hyperlipoproteinemia: histopathological and ultrastructural findings[J]. Can J Ophthalmol, 1991, 26(5): 273-279.
|
[16] |
McCarthy M, Innis S, Dubord P, et al. Panstromal Schnyder corneal dystrophy. A clinical pathologic report with quantitative analysis of corneal lipid composition[J]. Ophthalmology, 1994, 101(5): 895-901.
|
[17] |
Weiss JS. Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis)[J]. Trans Am Ophthalmol Soc, 2007, 105: 616-648.
|
[18] |
Takeuchi T, Furihata M, Heng HH, et al. Chromosomal mapping and expression of the human B120 gene[J]. Gene, 1998, 213(1-2): 189-193.
|
[19] |
Auw-Hadrich C, Witschel H. Corneal dystrophies in the light of modern molecular genetic research[J]. Ophthalmologe, 2002, 99(6): 418-426.
|
[20] |
Riebeling P, Polz S, Tost F, et al. Schnyder′s crystalline corneal dystrophy: Further narrowing of the linkage interval at chromosome 1p34.1—p36[J]. Ophthalmologe, 2003, 100(11): 979-983.
|
[21] |
Shearman AM, Hudson TJ, Andresen JM, et al. The gene for Schnyder′s crystalline corneal dystrophy maps to human chromosome 1p34.1—p36[J]. Hum Mol Genet, 1996, 5(10): 1667-1672.
|
[22] |
Theendakara V, Tromp G, Kuivaniemi H, et al. Fine mapping of the Schnyder′s crystalline corneal dystrophy locus[J]. Hum Genet, 2004, 114(6): 594-600.
|
[23] |
Orr A, Dube MP, Marcadier J, et al. Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy[J]. PLoS One, 2007, 2(8): e685.
|
[24] |
Weiss JS, Kruth HS, Kuivaniemi H, et al. Mutations in the UBIAD1 gene on chromosome short arm 1, region 36, cause Schnyder crystalline corneal dystrophy[J]. Invest Ophthalmol Vis Sci, 2007, 48(11): 5007-5012.
|
[25] |
Yellore VS, Khan MA, Bourla N, et al. Identification of mutations in UBIAD1 following exclusion of coding mutations in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy[J]. Mol Vis, 2007, 13: 1777-1782.
|
[26] |
McGarvey TW, Nguyen T, Tomaszewski JE, et al. Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder[J]. Oncogene, 2001, 20(9): 1042-1051.
|
[27] |
McGarvey TW, Nguyen T, Puthiyaveettil R, et al. TERE1, a novel gene affecting growth regulation in prostate carcinoma[J]. Prostate, 2003, 54(2): 144-155.
|
[28] |
McGarvey TW, Nguyen TB, Malkowicz SB. An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation[J]. J Cell Biochem, 2005, 95(2): 419-428.
|
[29] |
Nickerson ML, Kostiha BN, Brandt W, et al. UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy[J]. PLoS One, 2010, 5(5): e10760.
|
[30] |
Weiss JS. Schnyder′s dystrophy of the cornea[J]. A Swede-Finn connection. Cornea, 1992, 11(2): 93-101.
|
[31] |
Weiss JS, Khemichian AJ. Differential diagnosis of Schnyder corneal dystrophy[J]. Dev Ophthalmol, 2011, 48: 67-96.
|
[32] |
Weiss JS, Kruth HS, Kuivaniemi H, et al. Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function[J]. Am J Med Genet A, 2008, 146A(3): 271-283.
|
[33] |
Weiss JS, Wiaux C, Yellore V, et al. Newly reported p. Asp240Asn mutation in UBIAD1 suggests central discoid corneal dystrophy is a variant of Schnyder corneal dystrophy[J]. Cornea, 2010, 29(7): 777-780.
|
[34] |
Weiss JS. Schnyder crystalline dystrophy sine crystals. Recommendation for a revision of nomenclature[J]. Ophthalmology, 1996, 103(3): 465-473.
|
[35] |
Weiss JS. Corneal dystrophy classification[J]. Ophthalmology, 2009, 116(5): 1013-1014.
|
[36] |
Weiss JS, Moller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies[J]. Cornea, 2008, 27(S2): S1-83.
|
[37] |
Weiss JS, Moller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies[J]. Cornea, 2015, 34(2): 117-159.
|
[38] |
Jing Y, Liu C, Xu J, et al. A novel UBIAD1 mutation identified in a Chinese family with Schnyder crystalline corneal dystrophy[J]. Mol Vis, 2009, 15: 1463-1469.
|
[39] |
Jing Y, Wang L. Morphological evaluation of Schnyder′s crystalline corneal dystrophy by laser scanning confocal microscopy and Fourier-domain optical coherence tomography[J]. Clin Exp Ophthalmol, 2009, 37(3): 308-312.
|
[40] |
Kitazawa K, Wakimasu K, Kayukawa K, et al. Long-term outcome after penetrating keratoplasty in a pedigree with the G177E mutation in the UBIAD1 gene for Schnyder corneal dystrophy[J]. Cornea, 2018, 37(5): 554-559.
|
[41] |
Nakagawa K, Hirota Y, Sawada N, et al. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme[J]. Nature, 2010, 468(7320): 117-121.
|
[42] |
Xia Y, Midoun SZ, Xu Z, et al. Heixuedian (heix), a potential melanotic tumor suppressor gene, exhibits specific spatial and temporal expression pattern during Drosophila hematopoiesis[J]. Dev Biol, 2015, 398(2): 218-230.
|
[43] |
Dragh MA, Xu Z, Al-Allak ZS, et al. Vitamin K2 prevents lymphoma in Drosophila[J]. Sci Rep, 2017, 7(1): 17047.
|
[44] |
Vos M, Esposito G, Edirisinghe JN, et al. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency[J]. Science, 2012, 336(6086): 1306-1310.
|
[45] |
Mugoni V, Postel R, Catanzaro V, et al. Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis[J]. Cell, 2013, 152(3): 504-518.
|
[46] |
Wang X, Wang D, Jing P, et al. A novel Golgi retention signal RPWS for tumor suppressor UBIAD1[J]. PLoS One, 2013, 8(8): e72015.
|
[47] |
Huang Y, Hu Z. UBIAD1 protects against oxygen-glucose deprivation/reperfusion-induced multiple subcellular organelles injury through PI3K/AKT pathway in N2A cells[J]. J Cell Physiol, 2018, 233(9): 7480-7496.
|
[48] |
Fredericks WJ, Yin H, Lal P, et al. Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism[J]. Int J Oncol, 2013, 43(2): 638-652.
|
[49] |
Fredericks WJ, McGarvey T, Wang H, et al. The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression[J]. DNA Cell Biol, 2011, 30(11): 851-864.
|
[50] |
Fredericks WJ, Sepulveda J, Lai P, et al. The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes[J]. Oncotarget, 2013, 4(7): 1075-1092.
|
[51] |
Morales CR, Grigoryeva LS, Pan X, et al. Mitochondrial damage and cholesterol storage in human hepatocellular carcinoma cells with silencing of UBIAD1 gene expression[J]. Mol Genet Metab Rep, 2014, 1: 407-411.
|
[52] |
Hirota Y, Nakagawa K, Sawada N, et al. Functional characterization of the vitamin K2 biosynthetic enzyme UBIAD1[J]. PLoS One, 2015, 10(4): e0125737.
|
[53] |
Schumacher MM, Elsabrouty R, Seemann J, et al. The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase[J]. eLife, 2015, 4: e05560.
|
[54] |
Johnson BM, DeBose-Boyd RA. Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase[J]. Semin Cell Dev Biol, 2018, 81: 121-128.
|
[55] |
Jiang SY, Tang JJ, Xiao X, et al. Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase[J]. PLoS Genet, 2019, 15(7): e1008289.
|
[56] |
Jo Y, Hamilton JS, Hwang S, et al. Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice[J]. eLife, 2019, 8: e44396.
|
[57] |
Jun DJ, Schumacher MM, Hwang S, et al. Schnyder corneal dystrophy-associated UBIAD1 is defective in MK-4 synthesis and resists autophagy-mediated degradation[J]. J Lipid Res, 2020, 61(5): 746-757.
|
[58] |
Li W. Bringing bioactive compounds into membranes: The UbiA superfamily of intramembrane aromatic prenyltransferases[J]. Trends Biochem Sci, 2016, 41(4): 356-370.
|